GBCI vs UBSI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GBCI presents a stark contrast between aggressive growth and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the company exhibits impressive YoY revenue growth of 41.4% and earnings growth of 31.1%, the underlying financial health metrics are concerning. The stock currently trades at a premium to its Graham Number ($38.1) but below its growth-based intrinsic value ($58.7). The high dividend payout ratio of 82.91% combined with a bearish technical trend suggests limited immediate upside despite analyst 'buy' recommendations.
UBSI presents a stark contradiction between strong valuation and deteriorating fundamental health. While the stock trades significantly below its Graham Number ($56.24) and Intrinsic Value ($105.31), the Piotroski F-Score of 2/9 indicates severe weakness in financial health and operational efficiency. Despite impressive YoY earnings growth of 50.80% and consistent earnings beats, the bearish technical trend (10/100) and low insider sentiment suggest significant underlying risks that offset the attractive valuation.
Compare Another Pair
Related Comparisons
GBCI vs UBSI: Head-to-Head Comparison
This page compares Glacier Bancorp, Inc. (GBCI) and United Bankshares, Inc. (UBSI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.